Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Gardin
Gardin is a UK-based company specializing in advanced crop intelligence solutions. Their platform utilizes high-tech optical sensors and machine vision to monitor plant physiology in real-time, enabling growers to optimize yields, reduce resource usage, and improve crop quality. By providing actionable insights through chlorophyll fluorescence measurements, Gardin empowers producers to make data-driven decisions for enhanced agricultural outcomes.
- Sector: Consumer Staples
- Last known transaction date: Seed Venture, $4.5M, May 2025
- Why timing suggests a near-term transaction: A $4.5M seed round in May 2025 provides very limited runway — typically 12–15 months for a consumer staples company navigating product development and distribution buildout — suggesting Gardin is likely already in or approaching active Series A fundraising mode and could close a round by mid-to-late 2026 before capital runs thin.
View all private company data in Dakota Marketplace.
2. HAYA Therapeutics
HAYA Therapeutics is a biotechnology company specializing in precision RNA-guided medicines that target long non-coding RNAs (lncRNAs) to reprogram disease-driving cell states. Founded in 2019 by Dr. Samir Ounzain and Dr. Daniel Blessing, the company is headquartered in Lausanne, Switzerland, with laboratory facilities in San Diego, USA. HAYA's mission is to develop innovative therapies for a broad range of diseases, including cardiovascular and metabolic conditions, as well as cancer. The company's lead therapeutic candidate, HTX-001, is an antisense oligonucleotide targeting Wisper, a cardiac-specific lncRNA implicated in heart failure. HAYA has established strategic partnerships, including a significant collaboration with Eli Lilly and Company, to advance its pipeline of lncRNA-targeting precision medicines. In 2024, the co-founders received the inaugural Andreas & Thomas Struengmann Award for their entrepreneurial vision in life sciences.
- Sector: Health Care
- Last known transaction date: Series A Venture, $65M, May 2025
- Why timing suggests a near-term transaction: A $65M Series A in May 2025 is a substantial raise for a healthcare therapeutics company, typically supporting 24–36 months of clinical-stage runway, but the scale also signals aggressive pipeline advancement that accelerates burn — positioning HAYA for a Series B raise by late 2026 to mid-2027 as early clinical data readouts from lead programs provide the catalysts institutional investors need to underwrite the next round.
View all private company data in Dakota Marketplace.
3. aTENSION.life
aTENSION.life is an Austrian biotechnology company specializing in precision diagnostics for hypertension. Their flagship product, the ALDO+ testing platform, utilizes mass spectrometry to identify underlying causes of uncontrolled hypertension from a single blood sample, enabling personalized treatment plans and aiming to improve patient outcomes. The company is led by CEO Bernhard Klemen, CSO Marko Poglitsch, and CBO Katharina Wieser. In April 2025, aTENSION.life secured a $3 million seed funding round led by Wlanholding GmbH, with eQventure and VP Venture Partners participating as co-lead investors. The company plans to expand its services across the DACH region by 2026, with initial customers in Germany, Switzerland, and the USA.
- Sector: Information Technology
- Last known funding round: Seed Venture, $3M, May 2025
- Why timing suggests a near-term transaction: A $3M seed round in May 2025 represents a very lean capital base for an IT company, typically providing just 12–15 months of runway, suggesting aTENSION.life is likely already in active pre-Series A or Series A fundraising conversations and could be seeking to close a round by mid-2026 before runway constraints become critical.
View all private company data in Dakota Marketplace.
4. Exterra Carbon Solutions
Exterra Carbon Solutions is a Canadian cleantech innovator dedicated to mitigating climate change by transforming environmental liabilities into sustainable assets. Their proprietary technologies, LOW™ and ROC™, enable the extraction of valuable minerals and permanent CO₂ sequestration from mining waste, integrating the mining industry into the circular economy.
- Sector: Materials
- Last known funding round: Series A Venture, $20M, May 2025
- Why timing suggests a near-term transaction: A $20M Series A in May 2025 provides modest runway of 18–24 months for a materials-sector carbon solutions company, where project development, pilot plant costs, and regulatory timelines drive elevated burn — placing Exterra in the fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate commercial-scale viability and capitalize on continued investor appetite for carbon capture and industrial decarbonization technologies.
View all private company data in Dakota Marketplace.
5. Power to Hydrogen
Power to Hydrogen is a private company specializing in the development of low-cost anion exchange membrane (AEM) electrolyzers designed to produce clean hydrogen. Their technology integrates directly with renewable energy sources, enabling the production of high-pressure hydrogen and oxygen, thereby supporting the transportation and energy industries in achieving sustainability goals.
- Sector: Utilities
- Last known funding round: Series A Venture, $20M, May 2025
- Why timing suggests a near-term transaction: A $20M Series A in May 2025 provides 18–24 months of runway for a utilities-sector hydrogen company, where infrastructure development, electrolyzer deployment, and offtake agreement timelines drive meaningful capital consumption — positioning Power to Hydrogen for a Series B raise by late 2026 to early 2027 as pilot project milestones and the broader green hydrogen policy and commercialization landscape continue to mature.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
